Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production

scientific article published on 01 October 1993

Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8400286

P2093author name stringBondurant MC
Koury MJ
Sawyer ST
Wickrema A
Koury ST
Kelley LL
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)2340-2352
P577publication date1993-10-01
P1433published inBloodQ885070
P1476titleSurvival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production
P478volume82

Reverse relations

cites work (P2860)
Q33774503AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells
Q36407149Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin
Q35836904Anaemia in kidney disease: harnessing hypoxia responses for therapy
Q71917182Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors
Q35671724Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.
Q36655460Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.
Q42474645Cell death in the olfactory epithelium
Q39093732Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis
Q37155979Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation
Q38126361Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents
Q33178991Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis
Q36391075Differential gene expression during terminal erythroid differentiation
Q36250952EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress
Q37098040Erythropoietic agents and the elderly
Q37273207Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts
Q36664588Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
Q95840771Heterogeneity of Red Blood Cells: Causes and Consequences
Q37616538ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling
Q36462759Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
Q24563013Induction of ubiquitin-conjugating enzymes during terminal erythroid differentiation
Q39945328Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells
Q35847889Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins
Q36065828Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts
Q80565126Pharmacodynamics of recombinant human erythropoietin in murine bone marrow
Q57217591Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia
Q36354544Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.
Q34838835Protein phosphatase 2A catalytic subunit α (PP2Acα) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway.
Q33652700Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice
Q36468918Sublethal radiation injury uncovers a functional transition during erythroid maturation
Q24685620Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo
Q36914540Targeting erythroblast-specific apoptosis in experimental anemia
Q37378794The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
Q35446281The second transferrin receptor regulates red blood cell production in mice
Q28505824Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis
Q36363719Transforming growth factor beta 1 is an inducer of erythroid differentiation
Q35745175Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis